CTMM Becomes One of the World's Largest Public-Private Partnerships in Translational Medica... ( EINDHOVEN The Netherlands August ...)

CTMM Becomes One of the World's Largest Public-Private Partnerships in Translational Medical Research

Date:8/4/2009

EINDHOVEN, The Netherlands, August 4 /PRNewswire/ -- With today's final approval of a research project into prostate cancer, the Dutch CTMM (Center for Translational Molecular Medicine) today announced the successful completion of 265 million euro funding for translational (bench-to-bedside) medical research, making CTMM one of the largest public-private partnerships in the world. This pivotal point in the organisation's development firmly positions the Netherlands as one of the world's leading destinations for translational biomedical research.

"The 15 million euro allocated to this prostate cancer project, which brings the total allocated CTMM funding to 265 million euro, should enable the project team to make a real difference to the diagnosis and treatment of a disease that counts among the biggest killers of men," said Peter Luijten, CTMM Chief Scientific Officer.

With this final project approval, CTMM has fulfilled the initial objectives of its business plan by establishing public-private research consortia to address the world's most prevalent diseases. The CTMM project portfolio now comprises 18 projects conducting translational molecular medicine research into innovative new techniques for the diagnosis and treatment of cancer, cardiovascular, neurodegenerative and infectious/auto-immune disease. In total, more than 100 partners from industry and academia are involved in the projects, which are funded on the basis of 25% from industry, 25% from academia and 50% from the Dutch government.

About CTMM

CTMM (Center for Translational Molecular Medicine) is a Netherlands-based public-private partnership dedicated to the development of technologies in molecular medicine that enable early diagnosis and personalised treatment for oncology, cardiovascular, neurodegenerative and infectious/auto-immune disease - the four main areas of disease causing mortality and diminished qua
'/>"/>

SOURCE CTMM
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis
2. Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen-Deprivation Therapy
3. Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
4. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
5. PSA Screening Cuts Deaths by 20%, Says Worlds Largest Prostate Cancer Study
6. Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
7. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
8. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
9. The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications
10. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
11. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study

Post Your Comments:

(Date:11/25/2009)...f.,Nov.25/PRNewswire/--PraxisElectronicMedicalReco...fFamilyPhysicians,(AAFP)FamilyPracticeManagement(F...lquality,healthmaintenance,anddiseasemanagement,al...anked#1amongdoctorsindicatingtheirEMRhadapositivee...nkednumberoneinthecountryinprovidingexcellenttrain...

(Date:11/25/2009)...Nov.25/PRNewswire-FirstCall/--Pharmasset,Inc.(Nasd...ittedtodiscovering,developingandcommercializingnov...ultsforthefiscalyearendedSeptember30,2009.AtSeptem...ivalentsandshortterminvestments. ,, PipelineUp...e2bTrial ,, InlateNovember2009,anindependentD...

(Date:11/25/2009)....,Nov.25/PRNewswire/--TheFDAgrantedtraditionalappr...leosidereversetranscriptaseinhibitor(NNRTI).INTELE...tment-experiencedadultswhoareexperiencingvirologic...ntiretroviral(ARV)agents.Thetraditionalapprovalisb...andDUET-2.INTELENCEiscurrentlymarketedintheU.S.byT...

Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2 Pharmasset Reports Fiscal Year End 2009 Financial Results 2 Pharmasset Reports Fiscal Year End 2009 Financial Results 3 Pharmasset Reports Fiscal Year End 2009 Financial Results 4 Pharmasset Reports Fiscal Year End 2009 Financial Results 5 Pharmasset Reports Fiscal Year End 2009 Financial Results 6 Pharmasset Reports Fiscal Year End 2009 Financial Results 7 Pharmasset Reports Fiscal Year End 2009 Financial Results 8 U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2 U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3 U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4 Rabies 3A How to Protect Yourself and Your Pets 51990 1 Rabies 3A How to Protect Yourself and Your Pets 51990 2 Sanford Rose Associates Opens Minneapolis Office 13075 1 Sanford Rose Associates Opens Minneapolis Office 13075 2 Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 1 Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 2 Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 3 Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 4 Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 5 Econiche 28TM 29 Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 51988 6

[0] Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey [0] Pharmasset Reports Fiscal Year End 2009 Financial Results [0] U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine)

..., Jan. 7 Hyperion,Therapeutics, Inc., a privately...elopment and commercialization of hepatology and g...underserved patient populations with,unmet medical...been elected,to its Board of Directors and will se...cgi-bin/prnh/20070905/AQW076LOGO ), Mr. Ringo bri...

... AtriCure, Inc.,(Nasdaq: ATRC ), a medical device... products, today announced that results reporting ...oducts, which physicians have adopted to,treat atr...s of Thoracic,Surgery by Dr. James H. Wudel, a pro...braska Heart Hospital, Lincoln, Nebraska., Dr. Wu...

Other Medicine Technology:William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman 2 Positive Results Published Using AtriCure Minimally Invasive Products 2 Positive Results Published Using AtriCure Minimally Invasive Products 3 Positive Results Published Using AtriCure Minimally Invasive Products 4

William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman Positive Results Published Using AtriCure Minimally Invasive Products

(Date:11/25/2009)...ire/-SentinelleMedicalInc.,aleadingmanufacturerofb...hesasuiteofnewleadingedgeclinicalapplicationsonits...sRadiologicalSocietyofNorthAmerica(RSNA)annualmeet...eapplicationsleveragetheuniquehighqualityimagesgen...upportmultipleimagingmodalitiesformulti-parametric...

(Date:11/25/2009)...ments,Business,andPressJoinEfforttoEducate ,, ...gain,theNationalBipolarFoundationandtheMedicAlertF...ilStable"program,whichisnowbeingwidelyacceptedasap...,theNationalBipolarFoundationreceivedaproclamation...t.GovernorofLouisianaMitchLandrieu.TheNationalBipo...

(Date:11/25/2009)... too short to draw definite conclusions, experts s...ews) -- In diabetic patients with blocked coronary...tcomes at one year whether patients undergo bypass...earchers report. , Bypass surgery has been the ...nary artery disease. However, less invasive approa...

(Date:11/25/2009)...s few signs of trouble with the H1N1 vaccine, , ...The ongoing H1N1 swine flu pandemic may be driving...ger patients, a U.S. health official said Wednesda...mococcal infections around the country," Dr. Anne ...nization and Respiratory Diseases at the U.S. Cent...

(Date:11/25/2009)...tal cancer also can reverse a rare stomach disorde...the disease, researchers at Vanderbilt University ...ase causes thickening of the stomach lining, sever...anemia and swelling in the feet and ankles due to ...astric cancer. Previously, the only effective trea...

Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2 Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3 Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2 Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3 Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2 Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3 Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2 Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3 Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4 Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2

[1] Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology [0] First Time-Door is Open for Family Discussion of Bipolar Disorder [1] Stenting May Equal Bypass for Diabetic Heart Patients [0] Swine Flu Tied to Rise in Pneumonias Among Young [1] Vanderbilt scientists report first effective medical therapy for rare stomach disorder

... research that delivers,timely studies with operat...nsulting and early-stage commercialization is now ... research repository managed by research and,consu... links to each of the two new,studies at this addr...

...ges, effort to reduce costs , , ST. LOUIS, Feb. 9...unced today it is in the process of reducing its w... part of an overall cost-cutting program as the co...y suspension of product manufacturing and shipment...

...ith the holiday from fruit and wine to massage can..., Mich., Feb. 9 The sweet delights of Valentine,s...colate, wine and romance can be good for your hear...s, grapes and wine that can lower blood pressure a...

...g Clinicians Exchange (PCE) has formed a partnersh...tion (CDC) to provide immunization continuing educ...ysician assistants (PAs) throughout the United Sta...ut the year as part of the PCE national symposia s...

...ia panel to reveal secrets behind healthy changes ...lling author and RealAge cofounder Michael Roizen,...behavior and patient success when he addresses the...rmed her life, Dr. Roizen will relay insights he,s...

...ire-Asia/ -- Chindex International, Inc.,(Nasdaq: ...of Western healthcare,products and services in the...cial results for the third quarter of fiscal year ...8. Revenue,from the healthcare services division i...

Best Practice Database adds Research Highlighting the Value of Internal Consulting and Early-Stage Commercialization Groups in the Pharmaceutical Industry KV Pharmaceutical Company Reduces Workforce Valentine's Day Indulgences Can Be Heart Healthy Practicing Clinicians Exchange Forms Partnership with CDC Oprah Show Expert and RealAge Cofounder Headlines ePharma Talk Chindex International, Inc. Reports Third Quarter FY 2009 Financial Results

ProtecPoint Exit Protection System

... track the movement of controlled substances, crit...ee's "intellishelvess" are designed to perform thi...with no human intervention. Radio frequency identi...rdaSee Intellishelf™ product solutions incorp...

AgileTrac™ Bed and Room Manager

Assetrac Location & Protection System

Medicine Products:

ProtecPoint Exit Protection System VerdaSee Intellishelf™AgileTrac™ Bed and Room Manager Assetrac Location & Protection System

CTMM Becomes One of the World's Largest Public-Private Partnerships in Translational Medica...( EINDHOVEN The Netherlands August ...),Health